Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
7.3 Development of combined intervention strategies The revised section now discusses the potential of combined therapeutic approaches, such as the co-administration of natural bioactive compounds with probiotics or prebiotics, to synergistically regulate gut microbiota composition, restore intestinal barrier integrity, and reduce hepatic oxidative stress and inflammation
PMCID: PMC12196487
Following DAB development, nuclei were counterstained with hematoxylin, differentiated and blued in ammonia water, and coverslips were mounted with neutral resin
NIDDK-Tirzepatide offers cardiovascular protection by reducing the risk of heart disease
US$ 26.04
US$ 29.51
US$ 29.59
